D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 46 Citations 10,993 173 World Ranking 12132 National Ranking 116

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Cancer
  • Immune system

Her primary scientific interests are in Cancer research, Cell biology, Molecular biology, Cell cycle and STAT5. Her Cancer research study incorporates themes from Tyrosine kinase, ABL and Kinase. Within one scientific family, Veronika Sexl focuses on topics pertaining to Cyclin-dependent kinase under Cell biology, and may sometimes address concerns connected to Cyclin B.

Her Molecular biology research also works with subjects such as

  • Interleukin which intersects with area such as Interleukin 12, Cre recombinase, In vitro, Genetically modified mouse and Lymphokine-activated killer cell,
  • Bone marrow that connect with fields like Transplantation. Her Cell cycle research includes themes of PI3K/AKT/mTOR pathway, Immunology and Large-cell lymphoma. In STAT5, Veronika Sexl works on issues like STAT protein, which are connected to Endocrinology, Glucocorticoid, Fatty liver, Internal medicine and Glucocorticoid receptor.

Her most cited work include:

  • Differentiation of Type 1 ILCs from a Common Progenitor to All Helper-like Innate Lymphoid Cell Lineages (679 citations)
  • Stat5 Is Required for IL-2-Induced Cell Cycle Progression of Peripheral T Cells (502 citations)
  • Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1) (464 citations)

What are the main themes of her work throughout her whole career to date?

Her scientific interests lie mostly in Cancer research, Cell biology, Immunology, Leukemia and Haematopoiesis. Her Cancer research study combines topics from a wide range of disciplines, such as STAT5, breakpoint cluster region, Kinase and Cyclin-dependent kinase 6. Her research in Cell biology intersects with topics in Cell, Transcription factor and Cell growth.

Her Immunology research is multidisciplinary, relying on both Cytotoxic T cell and Interleukin 12. Veronika Sexl usually deals with Myeloid leukemia and limits it to topics linked to Tyrosine kinase and Chronic myelogenous leukemia. Her study looks at the intersection of STAT protein and topics like STAT1 with Carcinogenesis.

She most often published in these fields:

  • Cancer research (50.22%)
  • Cell biology (25.55%)
  • Immunology (22.03%)

What were the highlights of her more recent work (between 2018-2021)?

  • Cell biology (25.55%)
  • Cancer research (50.22%)
  • Cyclin-dependent kinase 6 (10.57%)

In recent papers she was focusing on the following fields of study:

Veronika Sexl mostly deals with Cell biology, Cancer research, Cyclin-dependent kinase 6, Leukemia and Haematopoiesis. Veronika Sexl mostly deals with STAT protein in her studies of Cell biology. Her Cancer research research integrates issues from NF-κB, STAT5 and Cytokine.

The concepts of her Leukemia study are interwoven with issues in Chromatin, Cell culture, Programmed cell death and STAT5B. Her work is dedicated to discovering how Cell, Immune system are connected with Signal transduction and other disciplines. Her Janus kinase research incorporates themes from Interleukin and Bone marrow.

Between 2018 and 2021, her most popular works were:

  • IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis. (28 citations)
  • Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity. (26 citations)
  • JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation (16 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Immune system

Her primary areas of investigation include Cancer research, Leukemia, STAT5, Innate immune system and Immune system. Her Cancer research research is multidisciplinary, incorporating elements of NF-κB, Kinase and Cyclin-dependent kinase 6. As part of the same scientific family, she usually focuses on Leukemia, concentrating on Programmed cell death and intersecting with PI3K/AKT/mTOR pathway, Peripheral T-cell lymphoma, Targeted therapy, Lymphoma and Cell culture.

Her work deals with themes such as Haematopoiesis and CD8, which intersect with STAT5. Her Innate immune system research incorporates elements of Signal transduction, Cell biology and JAK-STAT signaling pathway. Veronika Sexl works mostly in the field of Immune system, limiting it down to topics relating to Cell and, in certain cases, Interleukin, Bone marrow and Tumor microenvironment.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Differentiation of Type 1 ILCs from a Common Progenitor to All Helper-like Innate Lymphoid Cell Lineages

Christoph S.N. Klose;Christoph S.N. Klose;Melanie Flach;Melanie Flach;Luisa Möhle;Leif Rogell;Leif Rogell;Leif Rogell.
Cell (2014)

835 Citations

Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)

Mangeng Cheng;Veronika Sexl;Charles J. Sherr;Martine F. Roussel.
Proceedings of the National Academy of Sciences of the United States of America (1998)

720 Citations

Stat5 Is Required for IL-2-Induced Cell Cycle Progression of Peripheral T Cells

Richard Moriggl;David J Topham;Stephan Teglund;Veronika Sexl.
Immunity (1999)

654 Citations

Stat5 tetramer formation is associated with leukemogenesis

Richard Moriggl;Veronika Sexl;Lukas Kenner;Christopher Duntsch.
Cancer Cell (2005)

260 Citations

Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia.

Andrea Hoelbl;Christian Schuster;Boris Kovacic;Bingmei Zhu.
Embo Molecular Medicine (2010)

256 Citations

Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation

Andrea Hoelbl;Boris Kovacic;Marc A. Kerenyi;Olivia Simma.
Blood (2006)

254 Citations

Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5.

Veronika Sexl;Roland Piekorz;Richard Moriggl;Juerg Rohrer.
Blood (2000)

249 Citations

Stat5 Activation Is Uniquely Associated with Cytokine Signaling in Peripheral T Cells

Richard Moriggl;Veronika Sexl;Roland Piekorz;David Topham.
Immunity (1999)

233 Citations

A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis

Karoline Kollmann;Gerwin Heller;Christine Schneckenleithner;Wolfgang Warsch.
Cancer Cell (2013)

232 Citations

STIMULATION OF THE MITOGEN-ACTIVATED PROTEIN KINASE VIA THE A2A-ADENOSINE RECEPTOR IN PRIMARY HUMAN ENDOTHELIAL CELLS

Veronika Sexl;Gudrun Mancusi;Christoph Höller;Eva Gloria-Maercker.
Journal of Biological Chemistry (1997)

216 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Veronika Sexl

Richard Moriggl

Richard Moriggl

University of Veterinary Medicine Vienna

Publications: 85

Peter Valent

Peter Valent

Medical University of Vienna

Publications: 79

James P. Di Santo

James P. Di Santo

Institut Pasteur

Publications: 45

Eric Vivier

Eric Vivier

Aix-Marseille University

Publications: 40

Gabrielle T. Belz

Gabrielle T. Belz

University of Queensland

Publications: 39

Lothar Hennighausen

Lothar Hennighausen

National Institutes of Health

Publications: 37

Joseph C. Sun

Joseph C. Sun

Memorial Sloan Kettering Cancer Center

Publications: 33

Nicholas D. Huntington

Nicholas D. Huntington

Monash University

Publications: 32

Marco Colonna

Marco Colonna

Washington University in St. Louis

Publications: 32

Zhigang Tian

Zhigang Tian

University of Science and Technology of China

Publications: 31

Mathias Müller

Mathias Müller

University of Veterinary Medicine Vienna

Publications: 28

Warren J. Leonard

Warren J. Leonard

National Institutes of Health

Publications: 28

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 28

John J. O'Shea

John J. O'Shea

National Institutes of Health

Publications: 28

Fabrice Gouilleux

Fabrice Gouilleux

François Rabelais University

Publications: 25

James N. Ihle

James N. Ihle

St. Jude Children's Research Hospital

Publications: 23

Trending Scientists

Farok J. Contractor

Farok J. Contractor

Rutgers, The State University of New Jersey

Charles R. Doering

Charles R. Doering

University of Michigan–Ann Arbor

Nabil Gindy

Nabil Gindy

University of Nottingham

Ken Haenen

Ken Haenen

Hasselt University

Suzanne Cory

Suzanne Cory

Walter and Eliza Hall Institute of Medical Research

Mary L. Marazita

Mary L. Marazita

University of Pittsburgh

William R. Horwath

William R. Horwath

University of California, Davis

Ioannis Xenarios

Ioannis Xenarios

University of Lausanne

Zhifeng Xiao

Zhifeng Xiao

Chinese Academy of Sciences

Edward E. S. Nieuwenhuis

Edward E. S. Nieuwenhuis

Utrecht University

Christine Michel

Christine Michel

Fisheries and Oceans Canada

Ralph J. DiLeone

Ralph J. DiLeone

Yale University

Alan M. Leslie

Alan M. Leslie

Rutgers, The State University of New Jersey

David M. Mayer

David M. Mayer

University of Michigan–Ann Arbor

Aron Goldhirsch

Aron Goldhirsch

European Institute of Oncology

Margit Osterloh

Margit Osterloh

University of Zurich

Something went wrong. Please try again later.